EBOS Group Ltd
NZX:EBO
EBOS Group Ltd
NZX:EBO
Price:
22.27
NZD
0.09%
Market Closed
Market Cap:
NZ$4.6B
Relative Value
The Relative Value of one
EBO
stock under the Base Case scenario is
75.6
NZD.
Compared to the current market price of 22.27 NZD,
EBOS Group Ltd
is
Undervalued by 71%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EBO
Relative Value
Base Case
75.6
NZD
Undervaluation 71%
Multiples Across Competitors
EBO Competitors Multiples
EBOS Group Ltd Competitors
EBOS Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NZ |
|
EBOS Group Ltd
NZX:EBO
|
4.5B NZD | 0.3 | 17.8 | 12.3 | 12.3 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
115.7B USD | 0.3 | 26.7 | 18.7 | 21 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
69.1B USD | 0.2 | 42.5 | 14.9 | 18.9 | |
| US |
|
Cencora Inc
NYSE:COR
|
68.1B USD | 0.2 | 41.9 | 14.7 | 18.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
51.2B USD | 0.2 | 30.8 | 14.9 | 19.3 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.4B AUD | 2.6 | 33.4 | 24.8 | 24.8 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.9B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
61.4B CNY | 1.4 | 16.6 | 12.8 | 12.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD | 0.7 | 22 | 10.9 | 15.3 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66B HKD | 0.1 | 8.5 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
